Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 11—November 2023
Dispatch

Hepatitis C Virus Elimination Program among Prison Inmates, Israel

Lihi Eisen1Comments to Author , Zohar Mor1, Miriam Madar, Ron Rabinovitch, Yuval Dadon, Rivka Sheffer, Ehud Kaliner, and Liav Goldstein
Author affiliations: Ministry of Health, Tel-Aviv Department of Health, Tel Aviv, Israel (L. Eisen, R. Sheffer); Ashkelon Academic College, Ashkelon, Israel (Z. Mor); Central Department of Health, Ministry of Health, Ramla, Israel (Z. Mor, E. Kaliner); Israel Prison Service, Israel (M. Madar, R. Rabinovitch, L. Goldstein); Deputy Director Office, Ministry of Health, Jerusalem, Israel (Y. Dadon)

Main Article

Table 1

Characteristics of participants and nonparticipants in a hepatitis C virus elimination program among high-risk prison inmates, Israel*

Characteristics Participated in serology screening, n = 1,751 Did not participate in serology screening, n = 1,021 p value
Gender 0.01
M 1,701 (97.1) 1,009 (98.8)
F 49 (2.8) 12 (1.2)
Transgender
1 (<0.1)
0

Mean age, y (SD)
41.6 (12.2)
36.4 (11.1)
<0.01
Marital status
Married 454 (25.9) 193 (18.9) <0.01
Nonmarried† 1,282 (73.2) 812 (79.5)
Data not available
15 (0.9)
16 (1.6)

Education level, did not complete high school
1,358 (77.5)
810 (79.3)
0.2
Previously incarcerated 1,471 (84.0) 922 (90.3) <0.01
Mean number of imprisonments (SD)
8.2 (7.3)
8.7 (6.7)
<0.01
Smoker
1,442 (82.3)
885 (86.6)
0.03
Alcohol user
202 (11.5)
99 (9.7)
0.1
Risk criteria
Country of birth
Former Soviet Union and Romania 651 (37.2) 288 (28.2) <0.01
Israel 876 (50.0) 599 (58.7)
West Bank and Gaza Strip 115 (6.6) 54 (5.3)
Other countries 80 (4.6) 62 (6.1)
Data not available
29 (1.6)
18 (1.7)

Drug use
No drug use 371 (21.2) 182 (17.9) 0.03
Non–IV drug use 1,053 (60.1) 718 (70.3) <0.01
IV drug use
327 (18.7)
121 (11.8)
<0.01
HIV infection
18 (1.0)
2 (0.1)
0.01
Hepatitis B virus infection 71 (4.0) 13 (0.7) <0.01

*Values indicate no. (%) unless otherwise indicated. IV, intravenous. †Includes single, divorced, and widowed.

Main Article

1These authors contributed equally to this article.

Page created: September 29, 2023
Page updated: October 23, 2023
Page reviewed: October 23, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external